Emcure Pharmaceuticals launches solution for menopause wellness ‘Arth’ in India

Effective, holistic, science-backed targeted solutions for symptomatic treatment

Emcure Pharmaceuticals signs PPA with Sunsure Energy for solar power

The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants

Sanofi India inks distribution partnership with Emcure to expand reach of its cardiovascular brands

Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose

Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023

The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.

Emcure organizes awareness drive on World Cancer Day

The company is proud to be at the forefront of promoting cancer awareness and hopes to make a positive impact on the lives of its employees

Emcure conducts oral and health check-up camps for students in Pune

The camps were organised along with the doctors from Bharti Vidyapeeth Dental College and Hospital, Katraj, Pune, and Emcure’s occupational health centre (OHC) doctors

Emcure launches EmWocal campaign to raise women’s health issues

The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali

Emcure to launch oral Covid-19 drug soon

A toll-free helpline to be set up to help doctors and patients

Emcure Pharma files DRHP for proposed IPO, offer size in the range Rs 4,500-5000 crores

In FY21, the company reported a net profit of Rs 419 crores compared to Rs 101 crores in FY 20 and consolidated total income at Rs 6092 crores, up 19% Y-o-Y